{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:21:47Z","timestamp":1780939307679,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca corrente linea 3 I.N.M.I. L. Spallanzani IRCCS"],"award-info":[{"award-number":["Ricerca corrente linea 3 I.N.M.I. L. Spallanzani IRCCS"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Peritoneal fibrosis is a pathological alteration of the peritoneal membrane occurring in pro-inflammatory conditions, including peritoneal dialysis (PD), a renal replacement therapy. Characteristic of this process is the acquisition of invasive\/pro-fibrotic abilities by mesothelial cells (MCs) through induction of mesothelial to mesenchymal transition (MMT), a cell-specific form of EMT. Long noncoding (lnc) RNAs act as major players in physiologic regulatory circuitries of the cell. While LncRNA-H19 (lncH19), one of the first lncRNAs identified, has been broadly studied in tumorigenesis, its role in peritoneum fibrotic diseases has been scarcely addressed so far. Aim of this study was to investigate the role of H19 in the acquisition of a mesenchymal-like phenotype in primary fibrotic MCs from PD patients, and to elucidate epigenetic mechanisms controlling its expression. Genetic silencing\/ectopic expression experiments revealed that H19 promoted the expression of MMT markers while downregulating the epithelial marker E-Cadherin, and favored MC directed migration and invasion on a collagen matrix. Silencing of three main H19 isoforms revealed a synergistic activity in the induction of a mesenchymal phenotype. Treatment with MS-275, an HDAC1-3 specific inhibitor previously known to promote MMT reversal, as well as HDAC1 genetic silencing, downregulated lncRNA H19 expression. Bioinformatic analysis revealed a binding sequence of Wilm\u2019s Tumor Protein 1 (WT1), the master gene of mesothelial differentiation, on the H19 promoter at an area with multiple acetylation peaks partially overlapping the binding site of Specificity protein 1 (Sp1), another transcription factor active in cellular plasticity regulation. Genetic silencing and Chromatin Immunoprecipitation (ChIP) experiments demonstrated that HDAC1 inhibition promotes a switch between WT1 and Sp1 in H19 promoter occupancy, favoring an inhibitory effect of WT1 on H19 expression and the reversal towards an epithelial-like phenotype. Overall, we discovered an HDAC1-WT1\/Sp1-H19 axis potentially relevant to the design of new therapies aimed at counteracting peritoneal fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-025-07956-8","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T23:10:49Z","timestamp":1756595449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long noncoding RNA H19 promotes the acquisition of a mesenchymal-like invasive phenotype in mesothelial primary cells through an HDAC1-mediated WT1\/Sp1 switch"],"prefix":"10.1038","volume":"16","author":[{"given":"Giulio","family":"Bontempi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Michetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-7012","authenticated-orcid":false,"given":"Michela","family":"Terri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Battistelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3037-835X","authenticated-orcid":false,"given":"Alice","family":"Conigliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Garbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Montaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-607X","authenticated-orcid":false,"given":"Sergio","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-0003","authenticated-orcid":false,"given":"Clemens","family":"Zwergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-2382","authenticated-orcid":false,"given":"Antonello","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh","family":"Nahavandi Araghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Domenici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-971X","authenticated-orcid":false,"given":"Marco","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-8381","authenticated-orcid":false,"given":"Raffaele","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"7956_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s42003-018-0180-x","volume":"1","author":"T Koopmans","year":"2018","unstructured":"Koopmans T, Rinkevich Y. Mesothelial to mesenchyme transition as a major developmental and pathological player in trunk organs and their cavities. Commun Biol. 2018;1:170.","journal-title":"Commun Biol"},{"key":"7956_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fphar.2015.00113","volume":"6","author":"SE Mutsaers","year":"2015","unstructured":"Mutsaers SE, Birnie K, Lansley S, Herrick SE, Lim CB, Prele CM. Mesothelial cells in tissue repair and fibrosis. Front Pharm. 2015;6:113.","journal-title":"Front Pharm"},{"key":"7956_CR3","doi-asserted-by":"crossref","unstructured":"Trionfetti F, Marchant V, Gonzalez-Mateo GT, Kawka E, Marquez-Exposito L, Ortiz A, et al. Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis. Int J Mol Sci. 2023;24:5763.","DOI":"10.3390\/ijms24065763"},{"key":"7956_CR4","doi-asserted-by":"publisher","first-page":"607204","DOI":"10.3389\/fimmu.2021.607204","volume":"12","author":"M Terri","year":"2021","unstructured":"Terri M, Trionfetti F, Montaldo C, Cordani M, Tripodi M, Lopez-Cabrera M, et al. Mechanisms of peritoneal fibrosis: focus on immune cells-peritoneal stroma interactions. Front Immunol. 2021;12:607204.","journal-title":"Front Immunol"},{"key":"7956_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13046-023-02930-8","volume":"43","author":"M Terri","year":"2024","unstructured":"Terri M, Sandoval P, Bontempi G, Montaldo C, Tomero-Sanz H, de Turris V, et al. HDAC1\/2 control mesothelium\/ovarian cancer adhesive interactions impacting on Talin-1-alpha5beta1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling. J Exp Clin Cancer Res. 2024;43:27.","journal-title":"J Exp Clin Cancer Res"},{"key":"7956_CR6","doi-asserted-by":"publisher","first-page":"113613","DOI":"10.1016\/j.celrep.2023.113613","volume":"43","author":"A Yonemura","year":"2024","unstructured":"Yonemura A, Semba T, Zhang J, Fan Y, Yasuda-Yoshihara N, Wang H, et al. Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment. Cell Rep. 2024;43:113613.","journal-title":"Cell Rep"},{"key":"7956_CR7","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","volume":"92","author":"C Aufricht","year":"2017","unstructured":"Aufricht C, Beelen R, Eberl M, Fischbach M, Fraser D, Jorres A, et al. Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network. Kidney Int. 2017;92:824\u201335.","journal-title":"Kidney Int"},{"key":"7956_CR8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2533\/chimia.2022.448","volume":"76","author":"E Di Bello","year":"2022","unstructured":"Di Bello E, Noce B, Fioravanti R, Mai A. Current HDAC inhibitors in clinical trials. Chimia. 2022;76:448\u201353.","journal-title":"Chimia"},{"key":"7956_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4103\/0973-1482.137937","volume":"10","author":"KC Lakshmaiah","year":"2014","unstructured":"Lakshmaiah KC, Jacob LA, Aparna S, Lokanatha D, Saldanha SC. Epigenetic therapy of cancer with histone deacetylase inhibitors. J Cancer Res Ther. 2014;10:469\u201378.","journal-title":"J Cancer Res Ther"},{"key":"7956_CR10","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/ijc.25151","volume":"127","author":"A Hayashi","year":"2010","unstructured":"Hayashi A, Horiuchi A, Kikuchi N, Hayashi T, Fuseya C, Suzuki A, et al. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Int J Cancer. 2010;127:1332\u201346.","journal-title":"Int J Cancer"},{"key":"7956_CR11","doi-asserted-by":"publisher","first-page":"e54001","DOI":"10.1371\/journal.pone.0054001","volume":"8","author":"N Liu","year":"2013","unstructured":"Liu N, He S, Ma L, Ponnusamy M, Tang J, Tolbert E, et al. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One. 2013;8:e54001.","journal-title":"PLoS One"},{"key":"7956_CR12","doi-asserted-by":"publisher","first-page":"204062231986269","DOI":"10.1177\/2040622319862697","volume":"10","author":"X Lyu","year":"2019","unstructured":"Lyu X, Hu M, Peng J, Zhang X, Sanders YY. HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis. Ther Adv Chronic Dis. 2019;10:2040622319862697.","journal-title":"Ther Adv Chronic Dis"},{"key":"7956_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26319-2","volume":"8","author":"L Rossi","year":"2018","unstructured":"Rossi L, Battistelli C, de Turris V, Noce V, Zwergel C, Valente S, et al. HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. Sci Rep. 2018;8:8492.","journal-title":"Sci Rep"},{"key":"7956_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05398-0","volume":"13","author":"G Bontempi","year":"2022","unstructured":"Bontempi G, Terri M, Garbo S, Montaldo C, Mariotti D, Bordoni V, et al. Restoration of WT1\/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells. Cell Death Dis. 2022;13:965.","journal-title":"Cell Death Dis"},{"key":"7956_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24:430\u201347.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7956_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1158\/0008-5472.CAN-20-1764","volume":"81","author":"C Battistelli","year":"2021","unstructured":"Battistelli C, Garbo S, Riccioni V, Montaldo C, Santangelo L, Vandelli A, et al. Design and functional validation of a mutant variant of the LncRNA HOTAIR to counteract snail function in epithelial-to-mesenchymal transition. Cancer Res. 2021;81:103\u201313.","journal-title":"Cancer Res"},{"key":"7956_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7956_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0282-x","volume":"9","author":"MH Bao","year":"2018","unstructured":"Bao MH, Szeto V, Yang BB, Zhu SZ, Sun HS, Feng ZP. Long non-coding RNAs in ischemic stroke. Cell Death Dis. 2018;9:281.","journal-title":"Cell Death Dis"},{"key":"7956_CR19","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.7150\/ijbs.62573","volume":"17","author":"J Yang","year":"2021","unstructured":"Yang J, Qi M, Fei X, Wang X, Wang K. LncRNA H19: A novel oncogene in multiple cancers. Int J Biol Sci. 2021;17:3188\u2013208.","journal-title":"Int J Biol Sci"},{"key":"7956_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26901-9","volume":"12","author":"N Singh","year":"2021","unstructured":"Singh N, Ramnarine VR, Song JH, Pandey R, Padi SKR, Nouri M, et al. The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer. Nat Commun. 2021;12:7349.","journal-title":"Nat Commun"},{"key":"7956_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/carcin\/bgs381","volume":"34","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2013;34:577\u201386.","journal-title":"Carcinogenesis"},{"key":"7956_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13046-020-01619-6","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Huang W, Yuan Y, Li J, Wu J, Yu J, et al. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. J Exp Clin Cancer Res. 2020;39:141.","journal-title":"J Exp Clin Cancer Res"},{"key":"7956_CR23","doi-asserted-by":"publisher","first-page":"8625","DOI":"10.1096\/fj.202000073RRRRR","volume":"34","author":"T Cao","year":"2020","unstructured":"Cao T, Jiang Y, Li D, Sun X, Zhang Y, Qin L, et al. H19\/TET1 axis promotes TGF-beta signaling linked to endothelial-to-mesenchymal transition. FASEB J. 2020;34:8625\u201340.","journal-title":"FASEB J"},{"key":"7956_CR24","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s11255-023-03892-8","volume":"56","author":"W Zhong","year":"2024","unstructured":"Zhong W, Fu J, Liao J, Ouyang S, Yin W, Liang Y, et al. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition. Int Urol Nephrol. 2024;56:1987\u201399.","journal-title":"Int Urol Nephrol"},{"key":"7956_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04470-3","volume":"21","author":"T Zhao","year":"2023","unstructured":"Zhao T, Sun Z, Lai X, Lu H, Liu L, Li S, et al. Tamoxifen exerts anti-peritoneal fibrosis effects by inhibiting H19-activated VEGFA transcription. J Transl Med. 2023;21:614.","journal-title":"J Transl Med"},{"key":"7956_CR26","doi-asserted-by":"publisher","first-page":"3795060","DOI":"10.1155\/2022\/3795060","volume":"2022","author":"F Tang","year":"2022","unstructured":"Tang F, Zhang S, Wang H, Xu S, Yang S, Zhu X, et al. lncRNA H19 promotes Ox-LDL-induced dysfunction of human aortic endothelial cells through the miR-152\/VEGFA axis. J Health Eng. 2022;2022:3795060.","journal-title":"J Health Eng"},{"key":"7956_CR27","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1096\/fj.13-236828","volume":"28","author":"S Karki","year":"2014","unstructured":"Karki S, Surolia R, Hock TD, Guroji P, Zolak JS, Duggal R, et al. Wilms\u2019 tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis. FASEB J. 2014;28:1122\u201331.","journal-title":"FASEB J"},{"key":"7956_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/path.5438","volume":"251","author":"RA Catar","year":"2020","unstructured":"Catar RA, Chen L, Cuff SM, Kift-Morgan A, Eberl M, Kettritz R, et al. Control of neutrophil influx during peritonitis by transcriptional cross-regulation of chemokine CXCL1 by IL-17 and IFN-gamma. J Pathol. 2020;251:175\u201386.","journal-title":"J Pathol"},{"key":"7956_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s13046-020-01783-9","volume":"39","author":"XT Hu","year":"2020","unstructured":"Hu XT, Xing W, Zhao RS, Tan Y, Wu XF, Ao LQ, et al. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer. J Exp Clin Cancer Res. 2020;39:270.","journal-title":"J Exp Clin Cancer Res"},{"key":"7956_CR30","doi-asserted-by":"publisher","first-page":"1275833","DOI":"10.3389\/fphar.2023.1275833","volume":"14","author":"C Zichittella","year":"2023","unstructured":"Zichittella C, Loria M, Celesia A, Di Liberto D, Corrado C, Alessandro R, et al. Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells. Front Pharm. 2023;14:1275833.","journal-title":"Front Pharm"},{"key":"7956_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fcell.2019.00263","volume":"7","author":"XW Cheng","year":"2019","unstructured":"Cheng XW, Chen ZF, Wan YF, Zhou Q, Wang H, Zhu HQ. Long non-coding RNA H19 suppression protects the endothelium against hyperglycemic-induced inflammation via inhibiting expression of miR-29b target gene vascular endothelial growth factor a through activation of the protein kinase B\/endothelial nitric oxide synthase pathway. Front Cell Dev Biol. 2019;7:263.","journal-title":"Front Cell Dev Biol"},{"key":"7956_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/molehr\/gaz040","volume":"25","author":"Z Xu","year":"2019","unstructured":"Xu Z, Zhang L, Yu Q, Zhang Y, Yan L, Chen ZJ. The estrogen-regulated lncRNA H19\/miR-216a-5p axis alters stromal cell invasion and migration via ACTA2 in endometriosis. Mol Hum Reprod. 2019;25:550\u201361.","journal-title":"Mol Hum Reprod"},{"key":"7956_CR33","doi-asserted-by":"publisher","first-page":"20693","DOI":"10.1073\/pnas.1310201110","volume":"110","author":"P Monnier","year":"2013","unstructured":"Monnier P, Martinet C, Pontis J, Stancheva I, Ait-Si-Ali S, Dandolo L. H19 lncRNA controls gene expression of the Imprinted Gene Network by recruiting MBD1. Proc Natl Acad Sci USA. 2013;110:20693\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7956_CR34","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/jnci\/86.14.1070","volume":"86","author":"RJ van Gurp","year":"1994","unstructured":"van Gurp RJ, Oosterhuis JW, Kalscheuer V, Mariman EC, Looijenga LH. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst. 1994;86:1070\u20135.","journal-title":"J Natl Cancer Inst"},{"key":"7956_CR35","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","volume":"96","author":"A Saito","year":"1999","unstructured":"Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA. 1999;96:4592\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7956_CR36","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/BJ20070779","volume":"409","author":"N Khan","year":"2008","unstructured":"Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, et al. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J. 2008;409:581\u20139.","journal-title":"Biochem J"},{"key":"7956_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03231-6","volume":"24","author":"V Pecci","year":"2024","unstructured":"Pecci V, Troisi F, Aiello A, De Martino S, Carlino A, Fiorentino V, et al. Targeting of H19\/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer. Cancer Cell Int. 2024;24:56.","journal-title":"Cancer Cell Int"},{"key":"7956_CR38","doi-asserted-by":"publisher","first-page":"102250","DOI":"10.1016\/j.pupt.2023.102250","volume":"83","author":"H Guo","year":"2023","unstructured":"Guo H, Ren H, Han K, Li J, Dong Y, Zhao X, et al. Knockdown of HDAC10 inhibits POLE2-mediated DNA damage repair in NSCLC cells by increasing SP1 acetylation levels. Pulm Pharm Ther. 2023;83:102250.","journal-title":"Pulm Pharm Ther"},{"key":"7956_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00788-w","volume":"13","author":"L Zhang","year":"2025","unstructured":"Zhang L, Yang Y, Li Y, Wang C, Bian C, Wang H, et al. Epigenetic regulation of histone modifications in glioblastoma: recent advances and therapeutic insights. Biomark Res. 2025;13:80.","journal-title":"Biomark Res"},{"key":"7956_CR40","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/nar\/gkn356","volume":"36","author":"MS Makki","year":"2008","unstructured":"Makki MS, Heinzel T, Englert C. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. Nucleic Acids Res. 2008;36:4067\u201378.","journal-title":"Nucleic Acids Res"},{"key":"7956_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-015-0426-x","volume":"14","author":"A Conigliaro","year":"2015","unstructured":"Conigliaro A, Costa V, Lo Dico A, Saieva L, Buccheri S, Dieli F, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Mol Cancer. 2015;14:155.","journal-title":"Mol Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07956-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07956-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07956-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:16:18Z","timestamp":1780499778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07956-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7956"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07956-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The affiliation corrected affiliation for Azadeh Nahavandi Araghi is: Escuela de Doctorado, Universidad Aut\u00f3noma de Madrid, Madrid, Spain; Centro de Biolog\u00eda Molecular Severo Ochoa, CSIC-UAM, Madrid, Spain.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"663"}}